Ching-Fei Li

908 citations
11 papers · 713 · 1 hit paper · h-index 6

Impact in

  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis
  • Immunology top 10%
    • Galectins and Cancer Biology
    • T-cell and B-cell Immunology
    • Immune cells in cancer
    • Immunotherapy and Immune Responses

Papers in

    • Pancreatic and Hepatic Oncology Research 3
    • Cancer Immunotherapy and Biomarkers 2
    • Cancer Cells and Metastasis 1
    • PARP inhibition in cancer therapy 1
    • Galectins and Cancer Biology 3

Ching-Fei Li

9 papers receiving 706 citations

Ching-Fei Li's Hit Papers

Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy 2021 · 492 citations
4920+1+3Years since publication100200300400

Peers

Ching-Fei Li
Comparison fields: 5 of 60
  • Oncology 304
  • Immunology 202
  • Cancer Research 46
  • Genetics 25
  • Immunology and Allergy 13
Replace Dikla Gelbard-Solodkin with:
Dikla Gelbard-Solodkin Israel
Claudia Cocco Italy
Ivan Shabo Sweden
Lequn Li United States
John G. Facciponte United States
George A. Dominguez United States
Sigal Tavor Israel
Ileana Soto Mauldin United States
Amélien Sanlaville France
Christian Eisen Germany
Ching-Fei Li relative to Dikla Gelbard-Solodkin Israel Dikla Gelbard-Solodkin's profile →
Citations per field
00.5×1.5×2.2×
Dikla Gelbard-Solodkin · 1×
Citations per year

Countries citing papers authored by Ching-Fei Li

Since Specialization
Citations

This map shows the geographic impact of Ching-Fei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching-Fei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching-Fei Li more than expected).

Fields of papers citing papers by Ching-Fei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching-Fei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching-Fei Li. The network helps show where Ching-Fei Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Ching-Fei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ching-Fei Li Line = papers co-authored together Ching-Fei Li links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1
Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
Hit paper breakdown →
2021492
2 2019121
3 202234
4 202228
5
Erratum: The stabilization of PD-L1 by the endoplasmic reticulum stress protein GRP78 in triple-negative breast cancer.
202019
6 201713
7 20254
8 20241
9 20251
10 20260
11 20260

About Ching-Fei Li

Ching-Fei Li is a scholar working on Oncology, Immunology, Cell Biology, Molecular Biology and Surgery, having authored 11 papers that have together received 713 indexed citations. Recurring topics across this work include Galectins and Cancer Biology (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Epigenetics and DNA Methylation (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Cells and Metastasis (1 paper), Endoplasmic Reticulum Stress and Disease (1 paper), Bladder and Urothelial Cancer Treatments (1 paper) and PARP inhibition in cancer therapy (1 paper). The work is most often cited by research in Oncology (304 citations), Immunology (202 citations), Cancer Research (46 citations), Genetics (25 citations) and Immunology and Allergy (13 citations). Ching-Fei Li has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Ri‐Yao Yang, Mien‐Chie Hung, Linlin Sun, Hui Li, Jong‐Ho Cha, Jun Yao, Jennifer L. Hsu, Wei‐Chao Chang, Chao‐Kai Chou and Meisi Yan. Their work appears in journals such as Nature Communications, Journal of Biological Chemistry, Oncotarget, Nature Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact